ACI and Centre for Medicinal Cannabis (CMC) today launch the report Green Shoots – Sowing The Seeds Of The New UK Cannabinoid Market with a new assessment of the size of the UK consumer cannabidiol (CBD) sector.
ACI Submits Response On Behalf of our Members to ACMD’s Call for Evidence on Cannabinoids in CBD Products
Following a consultation with our members ACI have compiled a response to the Advisory Council on the Misuse of Drugs’ (ACMD) recent call for evidence on cannabinoids in CBD products.
ACI today publicly rebuts the content and claims made in a letter published and shared widely on social media on Friday 26 March 2021.
Experts from the Association for the Cannabinoid Industry (ACI) and Centre for Medicinal Cannabis (CMC) have put together a detailed safety review paper of THC – Health Guidance Levels for THC in CBD products: Safety Assessment & Regulatory Recommendations. The paper recommends further research and makes policy recommendations.
ACI Forms Exclusive Partnership with PR Agency Ingredient Communications to Offer B2B Comms Support for Members
Today ACI announced an exclusive partnership with the UK’s leading PR agency specialising in B2B communications in the food and nutrition sectors, Ingredient Communications.
ACI welcomes the recent update from the UK’s Food Standards Agency concerning the criteria of which CBD products can remain on sale in the UK as of 1st April 2021.